ARA-290 16 mg

Steroids Dragon Pharma Peptides

$70.00

Dragon Pharma ARA-290 16 mg – Synthetic EPO-Derived Peptide for Innate Repair Research

✔ Synthetic 11-amino-acid peptide ✔ Derived from erythropoietin (EPO) ✔ Activates innate repair receptor ✔ USA domestic shipping available

Dragon Pharma ARA-290 16 mg is a synthetic 11-amino-acid peptide, also known as cibinetide, derived from erythropoietin (EPO). This engineered peptide has been specifically designed to activate the body's innate repair receptor (IRR), a mechanism that reduces inflammation and neuropathic pain without stimulating red blood cell production, making it a valuable tool for investigating tissue repair and inflammatory pathways.

Each vial contains 16 mg of lyophilized ARA-290 in a 2 mL format, requiring reconstitution with bacteriostatic water before use. The unique design of ARA-290 separates its tissue-protective effects from the erythropoietic activity of full-length EPO, providing researchers with a targeted tool for studying innate repair mechanisms. For related research compounds, explore our peptides category and specifically SS-31 50 mg for complementary mitochondrial and tissue protection research.

What Makes ARA-290 Valuable in Research?

ARA-290 represents a significant advancement in the study of tissue repair and inflammation. By specifically targeting the innate repair receptor, this peptide activates cytoprotective signaling pathways without the erythropoietic side effects associated with full-length EPO. Its 11-amino-acid structure has been optimized to retain the tissue-protective properties of EPO while eliminating its hematopoietic activity.

Researchers value ARA-290 for its specificity and targeted mechanism of action. Its ability to reduce inflammation, promote tissue repair, and modulate neuropathic pain pathways makes it relevant to research areas including neurology, immunology, and regenerative medicine. For investigators exploring other aspects of neuroprotection, Semax offers complementary research avenues in neurological function and repair.

Current scientific literature on ARA-290 can be accessed through the PubMed database, where researchers can review peer-reviewed studies on its biological activity and experimental applications.

Key Research Applications for Dragon Pharma ARA-290

✔ Investigation of innate repair receptor signaling pathways
✔ Evaluation of anti-inflammatory mechanisms and cytokine modulation
✔ Research on neuropathic pain and neuroprotection
✔ Studies of tissue repair and regeneration
✔ Preclinical models of inflammatory and neurodegenerative conditions

For Research Purposes Only

ARA-290 16 mg is intended for research use only and is not approved for human consumption. Proper handling, reconstitution, and experimental protocols are essential for reliable results. For studies on neuropathic pain, BPC 157 provides additional research avenues in tissue protection and repair.

Dispatched within 24 hours in plain, discreet packaging.

Additional Information

Categories:

Steroids

Brand: Dragon Pharma

Manufacturer: Dragon Pharma

Dosage Info: <div class="tab-pane fade" id="offer-tabbody--dosage-and-usage" role="tabpanel"> <section class="tab-panel" id="panel-usage"> <h2>Dosage & Usage Guidelines</h2> <div class="info-card warning"> <p><strong>For research and laboratory use only.</strong> Dragon Pharma ARA-290 16 mg is a synthetic peptide derived from erythropoietin. Proper reconstitution, handling, and experimental design are essential for obtaining reliable data.</p> </div> <h3>Reconstitution Protocol</h3> <ul class="usage-highlights"> <li>✔ Use sterile bacteriostatic water for injection</li> <li>✔ Add appropriate volume to achieve desired concentration</li> <li>✔ Swirl gently to dissolve – do not shake vigorously</li> <li>✔ Store reconstituted solution at 2–8°C</li> </ul> <p>Reconstitute the lyophilized powder using bacteriostatic water to a concentration suitable for your research protocol. The 16 mg format allows for flexible dosing across a range of experimental models. Always use aseptic technique during preparation to maintain peptide integrity.</p> <h3>Typical Research Parameters</h3> <p>In research settings, ARA-290 is typically administered via subcutaneous or intravenous injection. Dosing schedules and concentrations vary widely depending on the experimental design, animal model, and specific research objectives.</p> <ul> <li>✔ Commonly used in inflammation and neuropathic pain studies</li> <li>✔ Often combined with histological and molecular analysis</li> <li>✔ Used to investigate innate repair receptor signaling pathways</li> <li>✔ Research models include inflammatory and neurodegenerative paradigms</li> </ul> <h3>Factors to Consider in Research Protocols</h3> <ul> <li>Targeted peptide with specific innate repair receptor activation</li> <li>Reconstitution stability is limited; prepare fresh solutions for each use</li> <li>Individual variation in response may be observed across subjects</li> <li>Storage conditions significantly impact peptide stability</li> </ul> <div class="info-card"> <p><strong>Research note:</strong> ARA-290 is a rationally designed peptide that selectively activates the innate repair receptor without stimulating erythropoiesis. Its 11-amino-acid structure represents a significant advancement in separating the tissue-protective and hematopoietic functions of erythropoietin, providing a targeted tool for investigating inflammation, pain, and tissue repair mechanisms.</p> </div> </section> </div>

Reviews:

(0 customer reviews)